SCAL OTC
Stem Cell Authority, Ltd.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +100.0%
1Y: +0.0%
3Y: -96.8%
5Y: -99.6%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$4K
+0.0% ▲
Net Income
-$4K
+0.0% ▲
EPS (Diluted)
$0.00
+0.0% ▲
EBITDA
-$4K
+0.0% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2001 | FY2002 | FY2023 |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 |
| Gross Margin | — | — | — |
| R&D Expenses | $0 | $0 | $0 |
| SG&A Expenses | $1K | $1K | $4K |
| Operating Expenses | $42K | $41K | $4K |
| Operating Income | -$42K | -$41K | -$4K |
| Operating Margin | — | — | — |
| Interest Expense | $0 | $0 | $0 |
| Income Before Tax | -$42K | -$41K | -$4K |
| Tax Expense | $0 | $0 | $0 |
| Net Income | -$42K | -$41K | -$4K |
| Net Margin | — | — | — |
| EPS (Diluted) | $-0.01 | $-0.01 | $0.00 |
| EBITDA | -$42K | -$41K | -$4K |
| Shares Outstanding | 6M | 6M | 971M |